Syndax Pharmaceuticals Inc (SNDX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $20.67
• Market Cap: $1.80B
• EPS: $-3.60
• 52-Week High: $22.73
• 52-Week Low: $8.58

Market Sentiment

Syndax Pharmaceuticals Inc currently has a Bullish sentiment score of 0.17.

About Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts, focused on developing innovative therapies for the treatment of cancer. The company's robust pipeline includes novel agents designed to address significant unmet medical needs in various malignancies, leveraging both immuno-oncology and epigenetic modulation strategies. Syndax is committed to advancing its clinical programs to improve outcomes for patients facing challenging cancer diag...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Syndax Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SNDX pay dividends?

Syndax Pharmaceuticals Inc (SNDX) does not currently pay a regular dividend.

What is SNDX's market cap?

Syndax Pharmaceuticals Inc (SNDX) has a market capitalization of $1.80B with a current stock price of $20.67.